Private Advisor Group’s EyePoint Pharmaceuticals EYPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-1,400
| Closed | -$7K | – | 1758 |
|
|
2020
Q3 | $7K | Buy |
1,400
+1,000
| +250% | +$5K | ﹤0.01% | 1553 |
|
|
2020
Q2 | $3K | Buy |
+400
| New | +$3K | ﹤0.01% | 3429 |
|
|
2020
Q1 | – | Sell |
-4,340
| Closed | -$67K | – | 1486 |
|
|
2019
Q4 | $67K | Hold |
4,340
| – | – | ﹤0.01% | 1574 |
|
|
2019
Q3 | $79K | Buy |
4,340
+400
| +10% | +$7.28K | ﹤0.01% | 1578 |
|
|
2019
Q2 | $65K | Buy |
3,940
+590
| +18% | +$9.73K | ﹤0.01% | 1613 |
|
|
2019
Q1 | $60K | Buy |
+3,350
| New | +$60K | ﹤0.01% | 1508 |
|
|
2018
Q4 | – | Sell |
-3,750
| Closed | -$134K | – | 1424 |
|
|
2018
Q3 | $134K | Buy |
+3,750
| New | +$134K | ﹤0.01% | 1520 |
|
|
2018
Q2 | – | Sell |
-3,000
| Closed | -$37K | – | 1342 |
|
|
2018
Q1 | $37K | Buy |
+3,000
| New | +$37K | ﹤0.01% | 1130 |
|
|
2017
Q4 | – | Sell |
-3,000
| Closed | -$37K | – | 1252 |
|
|
2017
Q3 | $37K | Sell |
3,000
-20
| -0.7% | -$247 | ﹤0.01% | 1449 |
|
|
2017
Q2 | $50K | Buy |
3,020
+20
| +0.7% | +$331 | ﹤0.01% | 1353 |
|
|
2017
Q1 | $49K | Sell |
3,000
-20
| -0.7% | -$327 | ﹤0.01% | 1391 |
|
|
2016
Q4 | $59K | Buy |
3,020
+1,000
| +50% | +$19.5K | ﹤0.01% | 1233 |
|
|
2016
Q3 | $57K | Sell |
2,020
-250
| -11% | -$7.05K | ﹤0.01% | 1091 |
|
|
2016
Q2 | $69K | Hold |
2,270
| – | – | ﹤0.01% | 1073 |
|
|
2016
Q1 | $61K | Hold |
2,270
| – | – | ﹤0.01% | 989 |
|
|
2015
Q4 | $109K | Hold |
2,270
| – | – | 0.01% | 1018 |
|
|
2015
Q3 | $83K | Hold |
2,270
| – | – | ﹤0.01% | 969 |
|
|
2015
Q2 | $86K | Hold |
2,270
| – | – | ﹤0.01% | 1010 |
|
|
2015
Q1 | $90K | Hold |
2,270
| – | – | 0.01% | 942 |
|
|
2014
Q4 | $93K | Buy |
2,270
+800
| +54% | +$32.8K | 0.01% | 922 |
|
|
2014
Q3 | $65K | Hold |
1,470
| – | – | ﹤0.01% | 1017 |
|
|
2014
Q2 | $64K | Hold |
1,470
| – | – | 0.01% | 867 |
|
|
2014
Q1 | $60K | Hold |
1,470
| – | – | 0.01% | 776 |
|
|
2013
Q4 | $58K | Buy |
+1,470
| New | +$58K | 0.01% | 720 |
|